Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 11.89%868.99M | 17.70%557.79M | 14.14%225.17M | 14.78%940.45M | 13.04%776.61M | 22.25%473.91M | 21.16%197.28M | -16.22%819.31M | -17.15%687.02M | -28.50%387.64M |
| Refunds of taxes and levies | 1.09%38.57M | 5.06%33.69M | 42.49%22.91M | 47.81%44.85M | 81.83%38.16M | 93.82%32.07M | 118.71%16.08M | -29.16%30.34M | -35.67%20.99M | -34.05%16.54M |
| Cash received relating to other operating activities | 79.32%18.91M | 16.42%21.31M | 240.65%26.32M | -17.94%13.07M | -20.35%10.55M | 44.65%18.3M | 44.19%7.73M | -39.71%15.93M | -31.45%13.24M | -42.18%12.65M |
| Cash inflows from operating activities | 12.26%926.48M | 16.88%612.79M | 24.12%274.4M | 15.34%998.37M | 14.43%825.32M | 25.77%524.27M | 25.95%221.09M | -17.34%865.59M | -18.15%721.24M | -29.25%416.84M |
| Goods services cash paid | 5.01%434.82M | 10.31%321.64M | 57.07%163.26M | 47.94%557.15M | 28.75%414.08M | 30.15%291.59M | -0.19%103.94M | -34.50%376.61M | -28.16%321.6M | -26.10%224.04M |
| Staff behalf paid | -5.09%157.83M | -6.84%114.68M | 18.13%70.98M | 16.99%187.97M | 37.35%166.29M | 37.95%123.09M | 29.24%60.08M | 11.86%160.67M | 9.32%121.07M | 12.61%89.23M |
| All taxes paid | 49.18%40.19M | 93.42%28.51M | 101.78%12.48M | 3.54%36.33M | -14.91%26.94M | -29.17%14.74M | -10.12%6.19M | -38.90%35.09M | -32.55%31.66M | -37.01%20.81M |
| Cash paid relating to other operating activities | 12.88%42.36M | 11.31%31.7M | -10.87%14.74M | 12.35%60.11M | -26.67%37.53M | 21.61%28.47M | 55.30%16.54M | 23.32%53.5M | 52.88%51.18M | 7.84%23.42M |
| Cash outflows from operating activities | 4.71%675.19M | 8.44%496.52M | 40.01%261.46M | 34.46%841.57M | 22.71%644.84M | 28.09%457.9M | 11.05%186.75M | -23.62%625.88M | -17.74%525.51M | -18.22%357.49M |
| Net cash flows from operating activities | 39.23%251.28M | 75.16%116.27M | -62.30%12.95M | -34.59%156.8M | -7.79%180.48M | 11.84%66.38M | 365.38%34.34M | 5.26%239.71M | -19.25%195.73M | -60.96%59.35M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 38.87%616.6M | 32.67%368.89M | 61.79%296.1M | 4.30%867.28M | -20.05%444.02M | -40.65%278.05M | -37.05%183.02M | -35.10%831.55M | -34.85%555.35M | -36.79%468.47M |
| Cash received from returns on investments | 0.00%156K | ---- | ---- | -16.67%156K | -16.67%156K | ---- | ---- | -25.00%187.2K | -25.00%187.2K | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -41.06%7.24M | -65.92%650.85K | 71,471.01%486.33K | -23.10%2.45M | 3,280.84%12.28M | 560.02%1.91M | -99.79%679.5 | 1,092.60%3.19M | 25.12%363.2K | 173.80%289.34K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --11.88M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.74%4.75K | --76.24K | --76.24K |
| Cash inflows from investing activities | 36.70%623.99M | 32.00%369.54M | 62.05%296.58M | 5.61%881.76M | -17.90%456.45M | -40.29%279.96M | -37.12%183.02M | -34.96%834.93M | -34.82%555.97M | -36.75%468.83M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -27.93%101.19M | -41.13%51.53M | 9.00%46.82M | 19.42%215.78M | 62.28%140.4M | 81.29%87.52M | 144.37%42.95M | 18.60%180.69M | 56.79%86.52M | 34.13%48.28M |
| Cash paid to acquire investments | -20.33%469.22M | -16.04%271.58M | -49.39%135.82M | 15.57%957.92M | 15.60%588.96M | 5.83%323.45M | 24.84%268.4M | -45.69%828.88M | -52.44%509.48M | -56.35%305.63M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15.89M | --16.08M | --16.08M |
| Cash paid relating to other investing activities | -85.53%1M | --1M | ---- | 66.67%1M | 9,869,393,071.43%6.91M | ---- | ---- | 399,999,900.00%600K | --0.07 | --0.13 |
| Cash outflows from investing activities | -22.39%571.41M | -21.14%324.1M | -41.34%182.64M | 14.49%1.17B | 20.29%736.27M | 11.08%410.97M | 33.87%311.35M | -38.87%1.03B | -45.66%612.08M | -49.74%369.99M |
| Net cash flows from investing activities | 118.79%52.59M | 134.68%45.44M | 188.79%113.94M | -53.26%-292.93M | -398.76%-279.82M | -232.55%-131.01M | -319.48%-128.33M | 51.59%-191.13M | 79.48%-56.1M | 1,853.93%98.84M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 307.88%14.28M | --14.28M | --1.3M | 33.31%8.54M | -45.37%3.5M | ---- | ---- | 139.54%6.41M | 139.54%6.41M | --6.41M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -62.86%1.3M | --1.3M | --1.3M | 33.31%8.54M | -45.37%3.5M | ---- | ---- | 139.54%6.41M | 139.54%6.41M | --6.41M |
| Cash from borrowing | -84.33%50.19M | -68.89%50.19M | -77.72%35.94M | 540.76%320.38M | 540.76%320.38M | --161.32M | --161.32M | --50M | --50M | ---- |
| Cash received relating to other financing activities | 3,161,922.33%25.09M | --14.32M | ---- | -93.86%125.95K | -99.99%793.44 | ---- | ---- | --2.05M | --7.8M | ---- |
| Cash inflows from financing activities | -72.35%89.55M | -51.16%78.78M | -76.92%37.24M | 462.89%329.05M | 404.43%323.88M | 2,418.02%161.32M | --161.32M | 2,085.68%58.46M | 2,300.70%64.21M | --6.41M |
| Borrowing repayment | -78.08%50.19M | -77.72%35.94M | --35.94M | 540.76%320.38M | --228.98M | --161.32M | ---- | --50M | ---- | ---- |
| Dividend interest payment | 113.04%28.32M | -77.62%329.72K | 148.34%329.72K | -34.40%14.97M | -41.31%13.29M | -93.45%1.47M | --132.77K | -49.85%22.82M | -50.27%22.65M | --22.5M |
| Cash payments relating to other financing activities | 209.58%19.3M | -89.96%742.23K | -22.27%2.22M | -35.82%19.95M | 319.26%6.23M | 601.17%7.39M | 1,932.03%2.86M | 3,047.70%31.09M | --1.49M | --1.05M |
| Cash outflows from financing activities | -60.64%97.8M | -78.25%37.01M | 1,186.45%38.49M | 241.95%355.3M | 929.73%248.51M | 622.42%170.18M | 2,026.38%2.99M | 123.48%103.9M | -47.01%24.13M | --23.56M |
| Net cash flows from financing activities | -110.94%-8.25M | 571.30%41.77M | -100.79%-1.25M | 42.24%-26.25M | 88.09%75.37M | 48.32%-8.86M | 112,616.68%158.33M | -3.72%-45.45M | 193.48%40.07M | ---17.15M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 43.59%-908.03K | -50.80%150.04K | 514.53%2.58M | 110.52%1.41M | -502.56%-1.61M | 226.01%304.97K | -730.00%-623.5K | -92.94%671.76K | -101.47%-267.15K | -101.80%-242.01K |
| Net increase in cash and cash equivalents | 1,252.34%294.71M | 378.21%203.63M | 101.26%128.22M | -4,331.55%-160.96M | -114.25%-25.58M | -151.99%-73.19M | -2.93%63.71M | 101.89%3.8M | 421.86%179.43M | -17.42%140.79M |
| Add:Begin period cash and cash equivalents | -47.21%179.97M | -47.21%179.97M | -47.21%179.97M | 1.13%340.93M | 1.13%340.93M | 1.13%340.93M | 1.13%340.93M | -37.40%337.13M | -37.40%337.13M | -37.40%337.13M |
| End period cash equivalent | 50.52%474.68M | 43.27%383.6M | -23.84%308.19M | -47.21%179.97M | -38.95%315.35M | -43.98%267.74M | 0.47%404.64M | 1.13%340.93M | 7.00%516.56M | -32.59%477.92M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.